This section is only updated periodically, may not be complete, and does not replace a search for the most current available data and literature!
| How I treat lymphoma in pregnancy | Comprehensive review of the management of lymphoma during pregnancy and key considerations | Dunleavy K, McLintock C. How I treat lymphoma in pregnancy. Blood. 2020 Nov 5;136(19):2118-2124. | https://pubmed.ncbi.nlm.nih.gov/32797210/ |
| Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. | In a cohort of 84 children born to mothers with hematological malignancies (29 acute leukemia, 26 Hodgkin’s disease, 29 non-Hodgkin lymphoma), 38 were exposed to chemotherapy during the first trimester. After a median follow-up of 18 years, no increased risk of mortality, malformations, somatic or psychiatric illness, or learning disabilities was observed. Notably, no cases of leukemia or lymphoma occurred. | Avilés A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001 Dec;2(3):173-7. | https://pubmed.ncbi.nlm.nih.gov/11779294/ |
| Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. | This report includes 54 patients treated with R-CHOP and several individual cases of rarer lymphomas. Findings include increased rates of prematurity (both iatrogenic and due to premature rupture of membranes), 44% small-for-gestational-age (SGA) infants, three cases of neonatal infection (one associated with neonatal neutropenia), and one case of reversible cardiomyopathy. | Maggen C, et al. International Network on Cancer Infertility Pregnancy (INCIP). Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. Br J Haematol. 2021 Apr;193(1):52-62. | https://pubmed.ncbi.nlm.nih.gov/32945547/ |
| Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. | In a cohort of 72 women who received antenatal chemotherapy, maternal outcomes were comparable to those of non-pregnant individuals. There was a higher incidence of preterm contractions and premature rupture of membranes (PROM). While the overall rate of small-for-gestational-age (SGA) infants was not increased, neonates exposed to chemotherapy had lower birth weights. | Maggen C, et al. International Network on Cancer, Infertility and Pregnancy. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. Lancet Haematol. 2019 Nov;6(11):e551-e561. | https://pubmed.ncbi.nlm.nih.gov/31564649/ |
| Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum. | No increased risk of early-onset breast cancer was observed after CT or V/Q scan during pregnancy; however, the risk of late-onset breast cancer remains unknown. | Burton KR, Park AL, Fralick M, Ray JG. Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum. J Thromb Haemost. 2018 May;16(5):876-885. | https://pubmed.ncbi.nlm.nih.gov/29450965/ |
